EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ATAI Life Sciences NV's enterprise value is $333.37 Mil.
ATAI Life Sciences NV's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $1.86 Mil. Therefore, ATAI Life Sciences NV's EV-to-Revenue for today is 178.94.
The historical rank and industry rank for ATAI Life Sciences NV's EV-to-Revenue or its related term are showing as below:
ATAI'
s EV-to-Revenue Range Over the Past 10 Years
Min: -254.67 Med: 337.9 Max: 1099.48
Current: 178.94
During the past 6 years, the highest EV-to-Revenue of ATAI Life Sciences NV was 1099.48. The lowest was -254.67. And the median was 337.90.
ATAI's EV-to-Revenue is ranked worse than 89.13% of 994
companies
in the Biotechnology industry
Industry Median: 7.16
vs ATAI: 178.94
ATAI Life Sciences NV EV-to-Revenue Historical Data
The historical data trend for ATAI Life Sciences NV's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ATAI Life Sciences NV's EV-to-Revenue
For the Biotechnology subindustry, ATAI Life Sciences NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ATAI Life Sciences NV's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ATAI Life Sciences NV's EV-to-Revenue falls into.
ATAI Life Sciences NV's current Enterprise Value is $333.37 Mil.
ATAI Life Sciences NV's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATAI Life Sciences NV (NAS:ATAI) EV-to-Revenue Explanation
ATAI Life Sciences NV's share price for today is $2.06.
ATAI Life Sciences NV's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATAI Life Sciences NV EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of ATAI Life Sciences NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATAI has been successfully added to your 